首页> 外文OA文献 >Rotigotine transdermal system for the management of motor function and sleep disturbances in Parkinson’s disease: Results from a 1-year, open-label extension of the RECOVER study

【2h】

Rotigotine transdermal system for the management of motor function and sleep disturbances in Parkinson’s disease: Results from a 1-year, open-label extension of the RECOVER study

机译：罗替戈汀透皮系统用于治疗帕金森氏病的运动功能和睡眠障碍：RECOVER研究的开放标签延长了一年

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Trenkwalder C.; Kies B.; Dioszeghy P.; Hill D.; Surmann E.; Boroojerdi B.; Whitesides J.; Chaudhuri K.R.;
展开▼
作者单位

展开▼
年度 2012
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Rotigotine transdermal system for control of early morning motor impairment and sleep disturbances in patients with Parkinson's disease. [J] . Giladi N, Fichtner A, Poewe W, Journal of neural transmission . 2010,第12期

机译：罗替戈汀透皮系统可控制帕金森氏病患者的清晨运动障碍和睡眠障碍。
2. Rotigotine transdermal system for control of early morning motor impairment and sleep disturbances in patients with Parkinson’s disease [J] . Nir Giladi, Andreas Fichtner, Werner Poewe, Journal of Neural Transmission . 2010,第12期

机译：罗替戈汀透皮系统可控制帕金森氏病患者的清晨运动障碍和睡眠障碍
3. Rotigotine transdermal system for long-term treatment of patients with advanced Parkinson's disease: Results of two open-label extension studies, CLEOPATRA-PD and PREFER [J] . LewittP.A., BoroojerdiB., SurmannE., Journal of neural transmission . 2013,第7期

机译：罗替戈汀透皮系统可长期治疗晚期帕金森氏病：两项开放标签扩展研究CLEOPATRA-PD和PREFER的结果
4. Sleep Dysfunctions Influence DecisionMaking in Undemented Parkinson'sDisease Patients: A Study in a VirtualSupermarket [C] . Giovanni ALBANI, Simona RASPELLI, Laura CARELLI, Medicine meets virtual reality 18/NextMed . 2011

机译：睡眠功能障碍影响无痴呆的帕金森氏病患者的决策：在虚拟超市中的一项研究
5. Prefrontal Cortical Modulation of Motor and Non-Motor Functions in Parkinson's Disease [D] . Chen, Witney . 2020

机译：帕金森病的电动机和非运动功能的前额叶皮质调制
6. Rotigotine transdermal system for long-term treatment of patients with advanced Parkinson’s disease: results of two open-label extension studies CLEOPATRA-PD and PREFER [O] . Peter A. LeWitt, Babak Boroojerdi, Erwin Surmann, -1

机译：Rotigotine透皮系统可长期治疗晚期帕金森氏病：两项开放标签延伸研究CLEOPATRA-PD和PREFER的结果
7. Rotigotine transdermal system for the management of motor function and sleep disturbances in Parkinson's disease:Results from a 1-year, open-label extension of the RECOVER study [O] . Trenkwalder, C., Kies, B., Dioszeghy, P., 2012

机译：罗替戈汀透皮系统用于治疗帕金森氏病的运动功能和睡眠障碍：RECOVER研究的开放标签延长了一年

Rotigotine transdermal system for the management of motor function and sleep disturbances in Parkinson’s disease: Results from a 1-year, open-label extension of the RECOVER study

著录项

引文网络

相似文献

相关主题

期刊订阅